The effect of alpha1-AR antagonists for lower urinary tract symptoms in patients undergoing prostate 125I brachytherapy for prostate carcinoma.
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2014
At a glance
- Drugs Silodosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- 01 May 2012 Planned end date Apr 2013 added as reported by University Hospital Medical Information Network - Japan record.
- 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.
- 18 Jun 2011 New trial record